MOONLAKE IMMUNOTHERAPEUTICS

Q1 2025 13F holders

CUSIP
61559X104
Type
Equity
Class
CLASS A ORD
Total Reported Value ($000, excl. options)
Manager Report date Value ($000) Shares Option type